Zika virus: An emergent neuropathological agent – Aug 2016

Annals of Neurology Version of Record online: 10 AUG 2016. DOI: 10.1002/ana.24748
Martyn K. White D.Phil.1, Hassen S. Wollebo Ph.D.1, J. David Beckham M.D.2,3, Kenneth L. Tyler M.D.2,3,4 andKamel Khalili Ph.D.1,*

Publishers wants $6 to rent the final PDF

 Download the Accepted PDF from VitaminDWiki

Nothing about Vitamin D

CONFLICT OF INTEREST is of interest
Dr. Khalili is a scientific advisor and holds equity in Excision Biotherapeutics, a biotech start-up
who has licensed the viral gene editing technology from Temple University for commercial
development and clinical trials

1919 visitors, last modified 20 Aug, 2016,
Printer Friendly Follow this page for updates